Whitney Amyot

Whitney’s work combines deep quantitative analyses, qualitative insights, and cutting-edge RWE data syntheses to bring actionable strategies to a broad range of global and start-up clients.

Core practice areas include opportunity analyses, and clinical or marketing strategy development for products in complicated and evolving markets. Whitney has served clients across a broad range of therapeutic areas, with a focus on hematology, oncology, immunologic disorders, and emerging cell and gene therapies. Prior to joining Putnam, Whitney served as part of the start-up team of a boutique life sciences strategy consulting firm. Whitney brings more than 10-years experience in scientific research to her current consulting career, including prior work in microbial infections, Genetics and Pharmacology.

She earned her Ph.D. in Molecular Microbiology from the Tufts University Graduate School of Biomedical Sciences, and graduated magna cum laude from Emory University with a B.S. in Biology.